Apollo Hospitals Enterprise Limited
APOLLOHOSP
株式のランク
#1762
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
株価
$83.93
最終同期: 2026-10-21
時価総額
$12.07B
変化（1日）
-1.23%
変化（1年）
-7.79%
国
IN
取引 Apollo Hospitals Enterprise Limited (APOLLOHOSP)
カテゴリー
Healthcare
Apollo Hospitals Enterprise Limited（APOLLOHOSP）の収益
Jun 2026 時点の収益 TTM: $2.92B
Apollo Hospitals Enterprise Limited の最新の財務報告によると、現在の収益 (TTM) は $2.92B です。2024 年には $2.29B の収益があり、これは 2023 年の $2.02B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Apollo Hospitals Enterprise Limited の収益履歴（2005 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $2.92B | 14.46% |
| 2025 | $2.55B | 11.48% |
| 2024 | $2.29B | 13.07% |
| 2023 | $2.02B | 4.65% |
| 2022 | $1.93B | 33.90% |
| 2021 | $1.44B | -3.37% |
| 2020 | $1.49B | 7.79% |
| 2019 | $1.39B | 9.39% |
| 2018 | $1.27B | 13.16% |
| 2017 | $1.12B | 19.27% |
| 2016 | $938.06M | 13.03% |
| 2015 | $829.89M | -3.94% |
| 2014 | $863.94M | 23.57% |
| 2013 | $699.16M | 12.64% |
| 2012 | $620.72M | 6.18% |
| 2011 | $584.62M | 29.57% |
| 2010 | $451.20M | 41.91% |
| 2009 | $317.96M | 4.74% |
| 2008 | $303.57M | 38.60% |
| 2007 | $219.03M | 26.76% |
| 2006 | $172.79M | 14.19% |
| 2005 | $151.32M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $78.01B | 2,574.64% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 647.81% |
US
|
|
| $3.89B | 33.53% |
SA
|
|
| $11.08B | 280.04% |
BR
|
